Atlas FDA

Remede® System

FDA premarket approval P160039/S003 · decided 2018-09-12

Approval details

PMA number
P160039
Supplement
S003
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Remede® System
Generic name
Implanted phrenic nerve stimulator for central sleep apnea
Applicant
Respicardia
Date received
2018-05-01
Decision date
2018-09-12
Days to decision
134 days
Decision code
APPR
Product code
PSR
Advisory committee
Anesthesiology
Expedited review
No
Location
Minnetonka, MN
Statement
Approval for a change in the material of the remede IPG from Hysol to EPO-TEK 301 as the Epoxy Resin Encapsulation material.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
RESPIGUIDE DELIVERY SYSTEM (K130378)Respicardia2013-10-17